any hormone-related effects are not established by the product information provided
The recommended BPC-157 dosage ranges from 200-500 mcg daily, administered via subcutaneous injection for optimal healing and recovery
The most common side effects include nausea (50-60% of users, most common during dose escalation but usually resolves within 2-4 weeks at each dose level), vomiting (25-30%, often transient and manageable), diarrhea (25-30%, usually mild and self-limiting), constipation (15-20%, manageable with dietary adjustments), and decreased appetite (20-30%, which is a desired effect but can be intense first)
What the Science Says GHK-Cu (glycyl-L-histidyl-L-lysine bound to copper) was first identified in human plasma in the 1970s
That is about 0.5% of the vial, truly negligible
Disease Management and Clinical Outcomes , 4 (1), 136-141